CTOs on the Move

Laerdal Medical

www.laerdal.com

 
Laerdal Medical Corporation maintains a national sales field team to assist customers with product information and demonstrations. Please use our contact form to request the name of your Laerdal Sales Representative.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.laerdal.com
  • 167 Myers Corners Rd
    Wappingers Falls, NY USA 12590
  • Phone: 845.297.7770

Executives

Name Title Contact Details

Similar Companies

LinkWin Technology Co.

LinkWin Technology Co. is a Puyallup, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Evermore Cannabis

The Highest Standards For Creating Quality Medical Cannabis Products. Evermore manufactures and processes medical cannabis in the State of Maryland.

Southeast Colorado Hospital and LTCC

Southeast Colorado Hospital and LTCC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Springfield, CO. To find more information about Southeast Colorado Hospital and LTCC, please visit www.sechosp.org

PMG of Santa Cruz

PMG of Santa Cruz is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Santa Cruz, CA. To find more information about PMG of Santa Cruz, please visit www.pmgscc.com

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.